Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Cadila Healthcare Limited
Cadila Healthcare Limited_20131212
  

Cadila Healthcare Limited patents

Recent patent applications related to Cadila Healthcare Limited. Cadila Healthcare Limited is listed as an Agent/Assignee. Note: Cadila Healthcare Limited may have other listings under different names/spellings. We're not affiliated with Cadila Healthcare Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cadila Healthcare Limited-related inventors




Date Cadila Healthcare Limited patents (updated weekly) - BOOKMARK this page
06/15/17Process for the preparation of dapagliflozin
06/08/17Process for preparation of androgen receptor antagonist
05/25/17Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
04/20/17Olaparib co-precipitate and preparation method thereof
03/30/17Novel composition for nonalcoholic fatty liver disease (nafld)
03/30/17Treatment for lipodystrophy
03/09/17Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
02/02/17Novel purification process of gonadotropin
01/12/17Novel heterobicyclic compounds as kappa opioid agonists
12/29/16Novel heterocyclic compounds
12/22/16Pharmaceutical compositions of sitagliptin
11/03/16Polymorphic forms of ivabradine hydrochloride
09/29/16Processes for the preparation of lorcaserin
09/08/16Novel heterocyclic compounds
09/01/16Formulation for gonadotropins
08/25/16Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
08/18/16Sustained-release compositions comprising topiramate and an alkalizer
07/28/16An amorphous vortioxetine and salts thereof
07/21/16Polymorphic form of pyrrole derivative and intermediate thereof
07/14/16Purification process for pth
07/07/16Improved process for the preparation of pyrrole derivatives
06/23/16N-cyanomethylamides as inhibitors of janus kinase
06/16/16A novel composition for nonalcoholic fatty liver disease (nafld)
05/26/16Stable pharmaceutical compositions of thyroid hormone drug
05/26/16Process for the preparation of apixaban
05/19/16Formula comprising a hypolipidemic agent
04/28/16An improved process for the preparation of apixaban and intermediates thereof
04/28/16Purification process for monoclonal antibodies
04/21/16A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
04/07/16Stable formulation of azacitidine or salts thereof and their process for preparation
03/24/16Polymorphic forms of lomitapide and its salts and processes for their preparation
03/24/16Amorphous form of canagliflozin and process for preparing thereof
03/24/16Oximino derivatives for the treatment of dyslipidemia
03/10/16Synergistic compositions
03/03/16Pharmaceutical compositions of teriflunomide
02/18/16Stable pharmaceutical compositions of mesalamine
02/11/16Process for the preparation of perampanel
01/28/16Directly compressed ospemifene compositions
01/28/16Polymorphic forms of ivabradine hydrochloride
01/14/16Stable pharmaceutical package comprising azilsartan medoxomil
01/14/16Stable pharmaceutical injectable compositions of voriconazole
01/07/16Method for determining formulation orientation of asymmetric multi-layered osmotic tablets
01/07/16Oral pharmaceutical compositions of ospemifene
01/07/16Process for preparation and purification of canagliflozin
10/29/15Amorphous form of dapagliflozin 1,2-propanediol
10/22/15Novel quinolone derivatives
10/15/15Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1
10/08/15Stable orally disintegrating tablets of hyoscyamine
10/08/15Amorphous form of apremilast
09/03/152-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
08/20/15Delayed release posaconazole tablets
07/30/15Process for preparation of androgen receptor antagonist
07/23/15Pharmaceutical compositions of mesalamine suppositories
07/16/15Pharmaceutical compositions of mesalamine
06/04/15Method of preparation of pitavastatin and pharmaceutical acceptable salts thereof
04/30/15Controlled release budesonide compositions
04/09/15Novel compounds for the treatment of dyslipidemia and related diseases
03/26/15Process for the preparation of sitagliptin phosphate
03/12/15Combined measles-malaria vaccine
03/12/15Pharmaceutical formulations of tnf-alpha antibodies
03/12/15Pharmaceutical compositions of sodium picosulfate, magnesium oxide and citric acid
03/05/15Method for treatment of pain and inflammation
02/19/15Compounds for the treatment of dyslipidemia and other diseases
02/19/15Amorphous form of linagliptin and process for preparation thereof
02/05/15Pharmaceutical compositions of levodopa and carbidopa
Patent Packs
01/15/15Process for preparing benzisothiazol-3-yl-piperazin-1-yl-methyl-cyclo hexylmethanisoindol-1,3-dione and its intermediates
01/15/15Amorphous form of apixaban, process of preparation and compositions thereof
01/08/15Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
12/25/14Processes and intermediates for preparing rivaroxaban
11/27/14Pharmaceutical compositions of lurasidone
11/27/14Sustained-release topiramate formulations
11/20/14Process for preparation of amorphous form of dasatinib
11/20/14Pharmaceutical compositions of lurasidone
10/02/14Processes for the preparation of lacosamide and intermediates thereof
08/28/14Pharmaceutical compositions of silodosin
07/17/14Stable pharmaceutical compositions of an s1p receptor agonist
07/17/14Extended release pharmaceutical compositions of fesoterodine
05/29/14Enzyme for the production of optically pure 3-quinuclidinol
05/29/14Pitavastatin calcium and process for its preparation
05/29/14Process for preparing fluticasone propionate/furoate
Patent Packs
05/01/14Process for the preparation of amorphous imatinib mesylate
05/01/14Process for preparing stable polymorphic form of erlotinib hydrochloride
04/24/14Process for the preparation and purification of azilsartan medoxomil
03/27/14Novel process to prepare pioglitazone via several novel intermediates
02/27/14Amorphous form of vilazodone hydrochloride and process for its preparation
02/20/14Novel salts of dpp-iv inhibitor
02/06/14Bilayer pharmaceutical compositions of naproxen
01/02/14Modified release pharmaceutical compositions memantine
12/19/13Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
12/19/13Treatment for lipodystrophy
12/12/13Novel process for the purification of tissue plasminogen activator
11/07/13Topical pharmaceutical compositions comprising etodolac
10/31/13Pharmaceutical compositions comprising nano size droplets of skin whitening agents
10/31/13Process for preparing an intermediate of sitagliptin via enzymatic conversion
10/24/13Pharmaceutical compositions of anti-acne agents
10/24/13Heterocyclic compounds suitable for the treatment of dyslipidemia
10/17/13Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
10/10/13Method for treatment of acne using pharmaceutical compositions of clindamycin
10/10/13Sustained release pharmaceutical compositions of donepezil
09/26/13Novel gpr 119 agonists
09/19/13Press-coated tablets of prednisone
09/19/13Expression vector for high level expression of recombinant proteins
08/22/13Pharmaceutical compositions of (r)-lansoprazole
08/15/13Extended release pharmaceutical compositions of pramipexole
08/08/13Pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
08/01/13Processes for the preparation of fesoterodine
07/25/13Substantially pure salts of febuxostat and processes for preparation thereof
07/04/13Stable pharmaceutical compositions comprising fesoterodine
06/13/13Modified release compositions of magnesium valproate
05/30/13Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase-1 inhibitors
Social Network Patent Pack
04/18/13Pharmaceutical compositions of sirolimus
03/07/13Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
10/18/12Polymorphic forms of o-desmethyl-venlafaxine succinate
08/16/12Processes for the preparation of lacosamide and intermediates thereof
08/09/12Process for the preparation of rapamycin derivatives
07/19/12Substituted benzamide derivatives as glucokinase (gk) activators
06/14/12Disubstituted benzamide derivatives as glucokinase (gk) activators
06/07/12Fusion protein systems suitable for high expression of peptides
05/17/12Combined measles-malaria vaccine
05/17/12Novel gpr 119 agonists
Patent Packs
05/10/12Novel compounds as inhibitors of renin
03/29/12Novel process to prepare pioglitazone via several novel intermediates
02/02/12Novel oxime derivatives
01/26/12Method for preparation of pitavastatin and its pharmaceutical acceptable salts thereof
12/08/11Thyroid receptor ligands
10/27/11Process for preparation of bosentan
09/01/11Expression vector and methods of producing high levels of proteins
09/01/11Process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine & new impurities in preparation thereof
06/16/11Process for the preparation of 7-ethyl-10-[4- (1-piperidino)- 1-piperidino] carbonyloxy-camptothecin hydrochloride trihydrate
03/24/11Process for preparing human g-csf
03/17/11Sulfoximine derivatives as factor xa inhibitors
03/17/11Process for preparing pure anastrozole
01/27/11Novel process to prepare pioglitazone via several novel intermediates
01/06/11Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
10/28/10Tricyclic pyrazole derivatives as cannabinoid receptor modulators
10/28/10Process for manufacturing rosuvastatin potassium and crystalline and amorphous forms thereof
09/30/10Purification process for lipopeptides
08/12/10Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
08/05/10Salts of clopidogrel and process for preparation
07/29/10Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures
07/29/10Process for the preparation of amorphous atorvastatin calcium
06/10/10Modified release clopidogrel formulation
04/01/10Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
03/25/10Formulations of peg-interferon alpha conjugates
11/05/09Substituted aralkyl derivatives
10/01/09Process for preparing pure anastrozole
05/21/09Thrombospondin-1 derived peptides and treatment methods
12/12/13Novel process for the purification of tissue plasminogen activator







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cadila Healthcare Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cadila Healthcare Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';